CNY 8.74
(-0.57%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 380.94 Million CNY | -70.09% |
2022 | 1.27 Billion CNY | -7.63% |
2021 | 1.37 Billion CNY | 76.65% |
2020 | 780.48 Million CNY | 3861.79% |
2019 | 19.7 Million CNY | -43.0% |
2018 | 34.56 Million CNY | -17.83% |
2017 | 42.06 Million CNY | 4.75% |
2016 | 40.15 Million CNY | -14.47% |
2015 | 46.95 Million CNY | 2.28% |
2014 | 45.9 Million CNY | 1.09% |
2013 | 45.41 Million CNY | 7.21% |
2012 | 42.35 Million CNY | -3.96% |
2011 | 44.1 Million CNY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 48.19 Million CNY | -15.63% |
2024 Q1 | 57.11 Million CNY | -59.64% |
2024 Q3 | 55.12 Million CNY | 14.4% |
2023 Q4 | 141.52 Million CNY | 127.75% |
2023 Q3 | 62.14 Million CNY | -27.88% |
2023 Q2 | 86.16 Million CNY | -53.04% |
2023 FY | 380.94 Million CNY | -70.09% |
2023 Q1 | 183.49 Million CNY | -57.83% |
2022 FY | 1.27 Billion CNY | -7.63% |
2022 Q1 | 276.59 Million CNY | 2.96% |
2022 Q4 | 435.16 Million CNY | 44.87% |
2022 Q3 | 300.38 Million CNY | 14.89% |
2022 Q2 | 261.44 Million CNY | -5.48% |
2021 Q4 | 268.63 Million CNY | 49.15% |
2021 Q1 | 80.35 Million CNY | -75.48% |
2021 FY | 1.37 Billion CNY | 76.65% |
2021 Q2 | 129.28 Million CNY | 60.89% |
2021 Q3 | 180.11 Million CNY | 39.32% |
2020 Q3 | 13.22 Million CNY | 112.33% |
2020 Q1 | 3.87 Million CNY | 301.77% |
2020 FY | 780.48 Million CNY | 3861.79% |
2020 Q4 | 327.78 Million CNY | 2378.29% |
2020 Q2 | 6.22 Million CNY | 60.93% |
2019 Q1 | 6.24 Million CNY | -10.95% |
2019 Q4 | -1.91 Million CNY | -124.96% |
2019 FY | 19.7 Million CNY | -43.0% |
2019 Q3 | 7.68 Million CNY | -41.05% |
2019 Q2 | 13.03 Million CNY | 108.67% |
2018 Q3 | 7.14 Million CNY | -43.74% |
2018 Q4 | 7.01 Million CNY | -1.83% |
2018 FY | 34.56 Million CNY | -17.83% |
2018 Q1 | 7.69 Million CNY | 0.82% |
2018 Q2 | 12.7 Million CNY | 65.08% |
2017 Q1 | 10.16 Million CNY | -1.22% |
2017 FY | 42.06 Million CNY | 4.75% |
2017 Q4 | 7.63 Million CNY | -27.76% |
2017 Q3 | 10.56 Million CNY | -22.91% |
2017 Q2 | 13.7 Million CNY | 34.9% |
2016 Q2 | 11.14 Million CNY | 20.69% |
2016 Q3 | 9.49 Million CNY | -14.8% |
2016 Q4 | 10.28 Million CNY | 8.33% |
2016 FY | 40.15 Million CNY | -14.47% |
2016 Q1 | 9.23 Million CNY | -40.1% |
2015 Q4 | 15.41 Million CNY | 36.4% |
2015 Q2 | 11.12 Million CNY | 22.03% |
2015 Q1 | 9.11 Million CNY | -47.37% |
2015 FY | 46.95 Million CNY | 2.28% |
2015 Q3 | 11.3 Million CNY | 1.62% |
2014 FY | 45.9 Million CNY | 1.09% |
2014 Q4 | 17.31 Million CNY | 62.62% |
2014 Q1 | 8.03 Million CNY | 0.0% |
2014 Q3 | 10.64 Million CNY | 7.55% |
2014 Q2 | 9.9 Million CNY | 23.15% |
2013 FY | 45.41 Million CNY | 7.21% |
2012 FY | 42.35 Million CNY | -3.96% |
2011 FY | 44.1 Million CNY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Cachet Pharmaceutical Co., Ltd. | 250.06 Million CNY | -52.341% |
Yixintang Pharmaceutical Group Co., Ltd. | 549.44 Million CNY | 30.667% |
Luyan Pharma Co.,Ltd. | 363.53 Million CNY | -4.79% |
Ji Yao Holding Group Co., Ltd. | -349.3 Million CNY | 209.056% |